Thiol-beta-lactamase: replacement of the active-site serine of RTEM beta-lactamase by a cysteine residue

Proc Natl Acad Sci U S A. 1982 Dec;79(23):7157-60. doi: 10.1073/pnas.79.23.7157.

Abstract

We describe a procedure by which the codon (AGC) for the active-site serine-70 of pBR322 beta-lactamase (penicillinase, penicillin amido-beta-lactamhydrolase, EC 3.5.2.6) is altered to that for cysteine (TGC). The pertinent nucleotide bases, A-G-C-A, positions 410-413, of pBR322 are excised by treating a limited HgiAI digest of pBR322 with the 3' leads to 5' exonuclease of T4 DNA polymerase. The new sequence, T-G-C-A, is inserted in two steps. First, the Kpn I molecular linker d(T-G-G-T-A-C-C-A) is ligated into the gap described above. The internal sequence G-T-A-C is then excised enzymatically with Kpn I and T4 DNA polymerase and the molecule is recircularized. This mutant gene, which codes for a thiol-beta-lactamase, confers on Escherichia coli K-12 hosts an ampicillin resistance that is reduced compared with that given by pBR322 yet is greater than that of E. coli lacking any intact beta-lactamase gene. Cell-free extracts of E. coli strains hosting the thiol-beta-lactamase gene possess a p-chloromercuribenzoate-sensitive beta-lactamase activity.

MeSH terms

  • Amino Acid Sequence
  • Ampicillin / pharmacology
  • Base Sequence
  • Binding Sites
  • Chloromercuribenzoates / pharmacology
  • Cysteine
  • Escherichia coli / enzymology
  • Genes
  • Genetic Engineering
  • Penicillin Resistance
  • Serine
  • Structure-Activity Relationship
  • beta-Lactamase Inhibitors
  • beta-Lactamases / genetics*
  • beta-Lactamases / metabolism

Substances

  • Chloromercuribenzoates
  • beta-Lactamase Inhibitors
  • Serine
  • Ampicillin
  • beta-Lactamases
  • Cysteine